Caribou Biosciences Correlations

CRBU Stock

USD 1.00 0.00 0.00%

The current 90-days correlation between Caribou Biosciences and Editas Medicine is 0.35 (i.e., Weak diversification). The correlation of Caribou Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Caribou Biosciences Correlation With Market

Modest diversification

The correlation between Caribou Biosciences and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.

Moving together with Caribou Stock

0.83	EYEN	Eyenovia	Pair Corr
0.73	MOLN	Molecular Partners	Pair Corr
0.71	SNDL	SNDL Inc	Pair Corr
0.91	CLDX	Celldex Therapeutics	Pair Corr
0.88	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.75	CRVS	Corvus Pharmaceuticals	Pair Corr
0.69	GKOS	Glaukos Corp	Pair Corr
0.73	LIVN	LivaNova PLC	Pair Corr
0.92	MODD	Modular Medical	Pair Corr
0.9	APYX	Apyx Medical	Pair Corr
0.85	SGHT	Sight Sciences	Pair Corr
0.92	SRDX	SurModics	Pair Corr
0.78	CNMD	CONMED	Pair Corr

Moving against Caribou Stock

0.85	FNA	Paragon 28	Pair Corr
0.82	CMRX	Chimerix Sell-off Trend	Pair Corr
0.79	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.86	NVRO	Nevro Corp	Pair Corr
0.79	LUCD	Lucid Diagnostics Buyout Trend	Pair Corr
0.66	NYXH	Nyxoah	Pair Corr
0.6	LUNG	Pulmonx Corp	Pair Corr
0.54	INMD	InMode	Pair Corr
0.4	KIDS	Orthopediatrics Corp	Pair Corr
0.88	BRK-A	Berkshire Hathaway	Pair Corr
0.88	BRK-B	Berkshire Hathaway	Pair Corr
0.78	FWEDF	Fireweed Zinc	Pair Corr
0.74	TOI	Oncology Institute Earnings Call This Week	Pair Corr
0.68	NHNCF	NAVER Corp	Pair Corr
0.53	TRGGF	Tarachi Gold Corp	Pair Corr

Related Correlations Analysis

	NTLA	EDIT	CRSP	VERV	BEAM	FATE	PRME	SANA	ADPT
NTLA		0.25	0.34	-0.19	0.49	0.91	0.7	-0.49	-0.4	NTLA
EDIT	0.25		0.78	0.14	0.56	0.02	0.08	0.01	0.42	EDIT
CRSP	0.34	0.78		0.39	0.78	0.13	0.2	0.08	0.49	CRSP
VERV	-0.19	0.14	0.39		0.42	-0.13	0.14	0.48	0.71	VERV
BEAM	0.49	0.56	0.78	0.42		0.37	0.34	-0.06	0.32	BEAM
FATE	0.91	0.02	0.13	-0.13	0.37		0.79	-0.4	-0.5	FATE
PRME	0.7	0.08	0.2	0.14	0.34	0.79		-0.01	-0.16	PRME
SANA	-0.49	0.01	0.08	0.48	-0.06	-0.4	-0.01		0.49	SANA
ADPT	-0.4	0.42	0.49	0.71	0.32	-0.5	-0.16	0.49		ADPT
	NTLA	EDIT	CRSP	VERV	BEAM	FATE	PRME	SANA	ADPT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FATE	+ 0.91	NTLA
PRME	+ 0.79	FATE
CRSP	+ 0.78	EDIT
BEAM	+ 0.78	CRSP
ADPT	+ 0.71	VERV
PRME	+ 0.7	NTLA

High negative correlations

ADPT	- 0.5	FATE
SANA	- 0.49	NTLA
SANA	- 0.4	FATE
ADPT	- 0.4	NTLA
VERV	- 0.19	NTLA
ADPT	- 0.16	PRME

Risk-Adjusted Indicators

There is a big difference between Caribou Stock performing well and Caribou Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Caribou Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NTLA	3.68	(0.41)	0.00	(0.34)	0.00	0.00	7.76	(7.56)	20.66
EDIT	6.85	0.45	0.03	0.05	8.87	(8.25)	12.20	(11.18)	119.53
CRSP	2.69	(0.07)	0.00	(0.14)	0.00	0.00	5.26	(4.88)	19.32
VERV	4.57	0.19	0.02	0.03	5.10	(5.08)	11.11	(8.35)	30.05
BEAM	3.41	(0.12)	0.00	(0.17)	0.00	0.00	7.58	(8.18)	23.04
FATE	4.80	(0.99)	0.00	(0.56)	0.00	0.00	9.29	(10.11)	22.21
PRME	4.59	(0.31)	0.00	(0.18)	0.00	0.00	10.03	(9.28)	25.37
SANA	7.71	1.40	0.17	0.46	6.56	(10.59)	10.15	(12.82)	178.30
ADPT	3.61	0.55	0.13	0.16	3.36	(4.79)	12.29	(5.91)	27.21

Caribou Biosciences Corporate Management

Sriram MBA	Chief Officer	Profile
Amy CFA	Vice Communications	Profile
Cindy Hayashi	VP HR	Profile
Ryan Fischesser	Interim Controller	Profile
Jason MBA	Chief Officer	Profile
JD Esq	Chief Secretary	Profile
Timothy MBA	Chief Officer	Profile

Trending Assets

CRSP

Crispr Therapeutics

41.94 0.97 2.37

ADPT

Adaptive Biotechnologies

7.56 0.21 2.86

FATE

Fate Therapeutics

0.91 -0.01 -1.09

EDIT

Editas Medicine

1.39 0.07 5.30

BEAM

Beam Therapeutics

23.64 1.05 4.65

SANA

Sana Biotechnology

2.34 0.06 2.63

PRME

Prime Medicine, Common

2.00 0.24 13.64

NTLA

Intellia Therapeutics

9.30 0.11 1.20

VERV

Verve Therapeutics

5.89 0.12 2.08

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC